Significance and Potential Role of Eosinophils in Non-Cystic Fibrosis Bronchiectasis.

J Allergy Clin Immunol Pract

Department of Pneumology, Hospital Universitario y Politécnico La Fe de Valencia, Valencia, Spain; CIBERes, Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. Electronic address:

Published: April 2023

Bronchiectasis is a complex and heterogeneous disease with a myriad of pulmonary and extrapulmonary etiologies. Bronchiectasis has a predominantly neutrophilic inflammatory profile. However, eosinophilic inflammation has also been documented in both the airways and the systemic circulation. Various diseases (eg, asthma, allergic bronchopulmonary aspergillosis, chronic rhinosinusitis with nasal polyps) characterized by heightened type 2 airway inflammatory responses, including blood or sputum eosinophilia, may coexist with bronchiectasis. Apart from those eosinophilic etiologies or comorbidities related to bronchiectasis, around 20% of patients with bronchiectasis have peripheral eosinophilia (at least 3% or 300 eosinophils/μL) with no identified concomitant disease (also termed "eosinophilic bronchiectasis"), whose roles have not been fully understood. The two key points regarding these observations are that eosinophils confer both bactericidal and antiviral properties against common pathogenic microorganisms that are usually detected in bronchiectasis, and that eosinophilic bronchiectasis has been associated with better therapeutic response to inhaled corticosteroids and other anti-T2 profile treatments. In this review, we summarize the most significant evidence regarding the role of eosinophils in patients with bronchiectasis, including the association of bronchiectasis with eosinophilic diseases (as etiologies or comorbidities), and existing data on eosinophilic bronchiectasis not related to eosinophilic disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2022.10.027DOI Listing

Publication Analysis

Top Keywords

bronchiectasis eosinophilic
12
bronchiectasis
11
role eosinophils
8
etiologies comorbidities
8
patients bronchiectasis
8
eosinophilic bronchiectasis
8
eosinophilic
6
significance potential
4
potential role
4
eosinophils non-cystic
4

Similar Publications

Sputum Microbiota Correlates With Metabolome and Clinical Outcomes in Asthma-Bronchiectasis Overlap.

Arch Bronconeumol

January 2025

Department of Allergy and Clinical Immunology, Department of Respiratory and Critical Care Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China; Guangzhou National Laboratory, Guangzhou, Guangdong, China. Electronic address:

Objectives: To investigate the microbiota and metabolome of patients with ABO compared with bronchiectasis and asthma, and determine the relevance with clinical characteristics, inflammatory endotype and exacerbation risks.

Methods: In this prospective cohort study, patients underwent comprehensive assessments, including sputum differential cell count, and sputum collection at baseline. Sputum microbiota was profiled via 16S rRNA gene sequencing and metabolome via liquid chromatography/mass spectrometry.

View Article and Find Full Text PDF

Background: The paradigm of bronchiectasis is shifting away from its exclusive characterization as a neutrophilic condition. Patients with bronchiectasis and high eosinophil levels have been found to have a specific phenotype, but the clinical effect of eosinopenia remains unclear.

Method: A retrospective, single-center, observational study was conducted at a tertiary medical center.

View Article and Find Full Text PDF

Background: Sensitization to mucus plugs, and bacterial colonization may coexist and relate to a refractory phenotype during follow-up in asthma with bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA).

Objective: This study aimed to clarify the features of -sensitized refractory asthma with bronchiectasis and determine the refractory phenotype in this population and ABPA.

Methods: This study included cases of the oldest available -specific IgE data and chest computed tomography images from a nationwide survey of refractory asthma with bronchiectasis.

View Article and Find Full Text PDF
Article Synopsis
  • Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Syndrome (BCOS) combines symptoms from both bronchiectasis and COPD, leading to challenges like a chronic cough, poor lung function, and frequent health issues.
  • The condition is influenced by various factors, such as genetics, infections, smoking, and pollution, necessitating thorough diagnostic methods like pulmonary tests and imaging.
  • Treatment is personalized and may involve medications to enhance lung function, but patients also face higher risks of cardiovascular problems, requiring careful management by healthcare providers.
View Article and Find Full Text PDF
Article Synopsis
  • The study compares various screening methods for allergic bronchopulmonary aspergillosis (ABPA) in asthma patients to find the most effective approach.
  • Serum IgE testing emerged as the best option, being the most cost-effective while providing high diagnostic accuracy.
  • Other methods, like total IgE and imaging, were more expensive and either missed cases or required many additional tests.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!